Latest "Texas Center for Proton Therapy" News Stories

13:35 EDT 19th July 2018 | BioPortfolio

Here are the most relevant search results for "Texas Center for Proton Therapy" found in our extensive news archives from over 250 global news sources.

More Information about Texas Center for Proton Therapy on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Texas Center for Proton Therapy for you to read. Along with our medical data and news we also list Texas Center for Proton Therapy Clinical Trials, which are updated daily. BioPortfolio also has a large database of Texas Center for Proton Therapy Companies for you to search.

Showing "Texas Center Proton Therapy" News Articles 1–25 of 14,000+

Thursday 19th July 2018

Medtronic Clinical Trial to Evaluate ECG Belt for Optimizing Heart Failure Therapy

DUBLIN - July 19, 2018 - Medtronic plc (NYSE: MDT) today announced first enrollments in a new clinical trial evaluating the ECG (electrocardiography) Belt Research System (ECG Belt) as a diagnostic tool for optimizing cardiac resynchronization therapy (CRT) for patients with heart failure. The first patient enrolled in the ECG Belt for CRT Response trial was at Mercy Medical Center...

Physicians Still Reluctant to Embrace Virtual Tech, Survey Finds

Rajiv LeventhalWhile consumers and physicians agree that virtual healthcare holds great promise for transforming care delivery, physicians still remain reluctant to embrace the technologies, according to a new Deloitte Center for Health Solutions survey.

Mustang Bio Completes Pre-IND Meeting with FDA for MB-102

Mustang Bio (NASDAQ:MBIO) has announced it has completed a pre-Investigational New Drug (pre_IND) meeting with the US Food and Drug Administration (FDA) for MB-102. As quoted in the press release: MB-102 is a CAR T therapy in development for the treatment of acute myeloid leukemia (AML), blastic plasmacytoid dendritic cell neoplasm (BPDCN) and high-risk myelodysplastic … Continued The post M...

CrownBio Supports Excellence in Translational Research with Grant Award that Funds Innovative PDX Model Development in Immuno-Oncology

"Cancer Research Center of Lyon iPS novel PDX models formulate new immune cell focused strategies" SAN DIEGO, July  19, 2018  (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, is proud to announce the award of it...

Vizient Now Accepting Applications for the 2018 Innovation Challenge

Vizient, Inc. today announced it is accepting applications from health care startup companies interested in competing in its sixth annual Innovation Challenge, which will take place October 3 as part of the 2018 Vizient Connections Summit to be held in Las Vegas. Applications are due by 5:00 p.m. CDT on Monday, August 6, 2018. The Innovatio...

Daily brief: Novartis spends big on ezcema, Kite invests, another gene therapy IPO

A round up from pharma, biotech and healthcare

20182023 Malaysia Glass Mat Market Report Status and Outlook [Report Updated: 15062018] Prices from USD $3360

In 2017, the Glass Mat market size was xx million USD in Malaysia, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.In Malaysia market, the top players include Owens Corning Jushi Group Binani Industries SaintGobain Taiwan Glass CPIC Nippon Electric Glass Nitto Boseki China Beihai Jiangsu Changhai Texas Fiberglass Jiangsu JiudingSp...

Eleven Wingate Healthcare Communities Receive 2018 Bronze National Quality Awards

Eleven Wingate Healthcare communities were recognized as 2018 recipients of the Bronze – Commitment to Quality Award presented by the American Health Care Association and National Center for Assisted Living. The award recognizes long-term and post-acute care providers that demonstrate a commitment to improving the quality of care for seniors and people w...

State Highlights: NYC To Pay Nurses Settlement After Excluding Them From ‘Physically Taxing’ Job Category; Boston Becomes Hot Spot For Tech Geared Toward Aging

Media outlets report on news from New York, Massachusetts, Texas, Missouri, Minnesota, Colorado, North Carolina, Virginia, Wisconsin, Georgia, California and Florida.

Kite and Gadeta Announce Strategic Collaboration to Advance Gamma Delta T Cell Receptor Technology for Solid Tumors

Kite, a Gilead Company (Nasdaq: GILD), and Gadeta B.V., a privately-held company focused on the discovery and development of novel cancer immunotherapies based on gamma delta T cell receptors (TCRs), have entered into a strategic collaboration to develop novel gamma delta TCR therapies in various cancers. Under the financial terms, Kite will provide resear...

Hemovent Reports “Stunning Results” from Completion of GLP Standardized in vivo Trial for Long-Term Use of Its Next-Gen ExtraCorporeal Membrane Oxygenation (ECMO) System Mobybox™

Key endpoints in all-six subjects — no hemolysis, no thrombosis at low anticoagulation and no functional device wear — will be used for CE mark registration and FDA submission of Mobybox™, the initial application of Hemovent’s Bionique™ platform. “The oxygenators and pumps looked as if they had just left cleanroo...

Bisphosphonate, Vitamin D Effects on Atherosclerosis in SLE

Combined treatment with bisphosphonate and vitamin D may help prevent the development of atherosclerosis in patients with SLE. Arthritis Research & Therapy

Novocure Announces 13 Presentations at American Society for Radiation Oncology 2018 Annual Meeting

The volume of Tumor Treating Fields presentations marks a record number of abstracts for Novocure at this conference Highlights include an analysis of the RTOG RPA scores in Novocure’s EF-14 phase 3 pivotal trial in newly diagnosed glioblastoma and the first presentation of an analysis of the correlation of dose density and survival outcomes in ...

Owlstone Medical Appoints Five Leading Experts to Scientific Advisory Board

Additions form a key strategic resource to advise on Breath Biopsy platform, product, and study development Cambridge, UK, July 19 2018: Owlstone Medical (or the “Company”), a diagnostics company developing a breathalyzer for disease, has announced the expansion of its Scientific Advisory Board (SAB) with the appointment of five leading experts in a range of high value disciplin...

Complementary Medicine and Refusal of Conventional Cancer Tx

Patients with cancer using complementary medicine and conventional therapy were more likely to decline subsequent conventional treatments, leading to shorter survival. Medscape Medical News

Pfizer moves haemophilia gene therapy into phase 3

US pharma giant Pfizer and partner Spark Therapeutics has begun a phase 3 trial of a gene therapy for patients with haemophilia B, which could see an end to patients needing constant injections to prevent bleeding. Pfizer's announcement sets up a ...

MedMen Opens First Branded Store in Las Vegas

In classic Las Vegas fashion, with red-feathered showgirls and an Elvis impersonator entertaining the crowds, MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQB: MMNFF) opened its first branded store in the tourist mecca and entertainment capital of the world. This press release features multimedia. View the full release here: h...

The Freedom from Cancer Startup Challenge Announces Companies Advancing 100+ Cancer Inventions

The Center for Advancing Innovation (CAI) announces winners of the Freedom from Cancer Startup Challenge (FCSC), generously supported by the Laura and John Arnold Foundation and MedImmune. BETHESDA, Md. (PRWEB) July 19, 2018 The Center for Advancing Innovation (CAI) announces winners of the Freedom from Cancer Startup Challenge (FCSC), generously supported by the Laura and John Arnold Foundation ...

Noble Health Care Center Celebrates 14th Annual Noble Health Care Day on Friday, July 20, 2018 and Announces New Outpatient Care

The award-winning senior care facility invites the public to attend the annual event NOBLE, Okla. (PRWEB) July 19, 2018 Noble Health Care Center, an award-winning senior care facility, announces plans for the 2018 Noble Health Care Center Day. The public is invited to attend the celebration on Friday, July 20 from 1 p.m. to 4 p.m. at the Noble Health Care Center at 1501 North 8th Street in Noble...

Roche's liver cancer drug, Tecentriq in combo with Avastin receives US FDA breakthrough therapy designation

Roche has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) as an initial

Critical Role of PRMT5 Protein Uncovered in the Production of Myelin

Researchers at the Advanced Science Research Center (ASRC) at The Graduate Center of The City University of New York report that they have discovered the role of a protein known as PRMT5 in the production of myelin and, ultimately, proper development and function of the central nervous system. The team hopes to determine how they can create favorable conditions for myelin-forming oligodendroc...

Say "Ahhh" to Get More Zzzz’s: Patients say "Good Night" to Sleep Issues with Oral Appliance Therapy

Collingswood Dentist Treats Obstructive Sleep Apnea, Snoring, with Oral Appliance Therapy COLLINGSWOOD, N.J. (PRWEB) July 19, 2018 Healthy teeth, healthy gums and now…healthy sleep? For those who have never consulted a dentist about treatments for sleep apnea and snoring, it may be time to make an appointment. Dental sleep medicine is a growing segment of dentistry that focuses on managing snor...

DOACs May Cut Cranial Bleed Risk, Up Survival in Women With AF

Female sex increases the risk for thromboembolism when other risk factors are present, and perhaps in the future, patient sex may be considered to guide AF therapy choices, says one expert. Medscape Medical News

CallTower Appoints Channel Director

Adam Pottorff joins the CallTower Team SOUTH JORDAN, Utah and BOSTON, Mass. (PRWEB) July 19, 2018 CallTower is proud to announce that Adam Pottorff, a driven channel professional has joined their team. With more than ten years of strategic, result-oriented Channel experience and a record of excellence in leading business-growth initiatives, Adam will deliver his expertise as CallTower’s Channel...

AHF Calls for International AIDS Conference (IAC) Participants and the World to “Keep the Promise” on HIV/AIDS

As Amsterdam prepares to welcome over 20,000 conference-goers, the largest global AIDS organization posts provocative advocacy ads throughout the city and at Schiphol Airport reminding people that there is still much to be done in the global fight against HIV/AIDS. One striking ad notes: “AIDS Yearly Deaths: 1 million. Amsterdam Population: 900,...

Quick Search


News Quicklinks